152 related articles for article (PubMed ID: 30605942)
21. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
22. [Ocular manifestations of syphilitic uveoretinitis in patients co-infected with human immunodeficiency virus].
Zhang R; Qian J; Wang Z; Yuan Y
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):739-45. PubMed ID: 26693768
[TBL] [Abstract][Full Text] [Related]
23. Hypotony maculopathy in a patient with HLA-B27-associated uveitis.
Roe R; Branco BC; Cunningham ET
Ocul Immunol Inflamm; 2008; 16(3):107-8. PubMed ID: 18569798
[TBL] [Abstract][Full Text] [Related]
24. Acantholytic dyskeratotic acanthoma: a possible skin adverse event of vemurafenib treatment.
Komori T; Otsuka A; Kaku Y; Honda T; Kabashima K
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e474-e475. PubMed ID: 28426905
[No Abstract] [Full Text] [Related]
25. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
Hanna KS
Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
[TBL] [Abstract][Full Text] [Related]
26. Vogt-Kayanagi-Harada-Like Uveitis Induced by Dabrafenib/Trametinib Therapy for Cutaneous Malignant Melanoma.
Kaymak NZ; Kaplan AT
Ophthalmic Surg Lasers Imaging Retina; 2023 Aug; 54(8):477-480. PubMed ID: 37535619
[TBL] [Abstract][Full Text] [Related]
27. Three cases of tubulointerstitial nephritis and uveitis syndrome with different clinical manifestations.
Nagashima T; Ishihara M; Shibuya E; Nakamura S; Mizuki N
Int Ophthalmol; 2017 Jun; 37(3):753-759. PubMed ID: 27511057
[TBL] [Abstract][Full Text] [Related]
28. Case of severe acneiform eruptions associated with the BRAF inhibitor vemurafenib.
Ansai O; Fujikawa H; Shimomura Y; Abe R
J Dermatol; 2017 Mar; 44(3):e15-e16. PubMed ID: 27511106
[No Abstract] [Full Text] [Related]
29. Central retinal vein occlusion associated with vemurafenib use in metastatic skin melanoma.
Yang SY; Chen SN
Kaohsiung J Med Sci; 2018 Sep; 34(9):535-536. PubMed ID: 30173784
[No Abstract] [Full Text] [Related]
30. [Severe panuveitis in a metastatic cutaneous melanoma patient treated with vemurafenib].
Boiché M; Conart JB; Angioi-Duprez K
J Fr Ophtalmol; 2018 Jun; 41(6):e291-e292. PubMed ID: 29908650
[No Abstract] [Full Text] [Related]
31. Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab.
Navarro-Perea C; Garcia-Gonzalez J; Perez-Blazquez E
Indian J Ophthalmol; 2019 Dec; 67(12):2075-2077. PubMed ID: 31755465
[TBL] [Abstract][Full Text] [Related]
32. Reaccion acneiforme noduloquistica secundaria a vemurafenib con buena respuesta a isotretinoina oralSevere acneiform eruption associated with vemurafenib with response to isotretinoin.
Elosua-Gonzalez M; Lopez-Estebaranz JL; Garcia-Zamora E; Vela-Ganuza M; Rodrigez-Vasquez X
Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677858
[TBL] [Abstract][Full Text] [Related]
33. Ischemic retinopathy and uveitis in a patient with tetralogy of Fallot.
Wu WC; Lai CC; Su WJ; Chen TL; Hwang YS; Lin KK; Kao LY
Ophthalmology; 2005 Nov; 112(11):1936-40. PubMed ID: 16271318
[TBL] [Abstract][Full Text] [Related]
34. Systematic review and meta-analysis of prevalence of dermatological toxicities associated with vemurafenib treatment in patients with melanoma.
Chen P; Chen F; Zhou B
Clin Exp Dermatol; 2019 Apr; 44(3):243-251. PubMed ID: 30280426
[TBL] [Abstract][Full Text] [Related]
35. [Post-streptococcal uveitis].
Viel A; Kolyvras N; Catherine J; Relvas L; Judice M; Caspers L; Willermain F
J Fr Ophtalmol; 2011 Apr; 34(4):256.e1-6. PubMed ID: 21444125
[TBL] [Abstract][Full Text] [Related]
36. A Case of Perforating Folliculitis Induced by Vemurafenib.
Shiraishi K; Masunaga T; Tohyama M; Sayama K
Acta Derm Venereol; 2019 Feb; 99(2):230-231. PubMed ID: 30281138
[No Abstract] [Full Text] [Related]
37. Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.
Willis MD; Pickersgill TP; Robertson NP; Lee RWJ; Dick AD; Carreño E
Int Ophthalmol; 2017 Oct; 37(5):1229-1233. PubMed ID: 27730316
[TBL] [Abstract][Full Text] [Related]
38. TINU-associated retinal pigment epithelium detachments: a possible novel posterior segment feature.
Sheth HG; Laverde-Konig T; Raina J
Int Ophthalmol; 2009 Jun; 29(3):179-81. PubMed ID: 18188506
[TBL] [Abstract][Full Text] [Related]
39. New onset of uveitis during infliximab treatment: A case report.
Bouladi M; Ben Othmen A; Sawssen M; Kalou M; Laater A; El Fekih L
Tunis Med; 2024 Jan; 102(1):58-60. PubMed ID: 38545732
[TBL] [Abstract][Full Text] [Related]
40. Drug reaction with eosinophilia and systemic symptoms syndrome induced by combination of vemurafenib and cobimetinib in melanoma: A series of 11 cases.
Brégeon B; Bernier C; Josselin N; Peuvrel L; Le Moigne M; Saint-Jean M; Quéreux G
J Am Acad Dermatol; 2019 Feb; 80(2):558-562. PubMed ID: 30081108
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
